Measurement of Mullerian inhibiting substance facilitates management of boys with microphallus and cryptorchidism

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 8, 2002, Pages 3598-3602

  Misra, Madhusmita ^a   MacLaughlin, David T ^a   Donahoe, Patricia K ^b   Lee, Mary M ^a,c   Massachusetts, ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b DUKE UNIVERSITY   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUELLERIAN INHIBITING FACTOR;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; CRYPTORCHISM; GENE MUTATION; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROPENIS; MUELLERIAN DUCT; PATIENT MONITORING; PRIORITY JOURNAL; SEX HORMONE DETERMINATION;

MICROPHALLUS;

EID: 0036342730     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.87.8.8742     Document Type: Article

References (40)

1. Mullerian inhibiting substance: An instructive developmental hormone with diagnostic and possible therapeutic applications
2. Mullerian inhibiting substance: A sensitive marker of gonadal function
3. Anti-Mullerian hormone: The Jost factor
4. New insights into Mullerian inhibiting substance and its mechanism of action
5. Anti-Mullerian hormone in early human development
6. Expression of anti-Mullerian hormone during normal and pathological gonadal development: Association with differentiation of Sertoli and granulosa cells
7. Mullerian inhibiting substance in humans: Normal levels from infancy to adulthood
8. An enzyme linked immunoassay for anti-Mullerian hormone: A new tool for the evaluation of testicular function in infants and children
9. An immunoassay to detect human Mullerian inhibiting substance in males and females during normal development
10. Serum levels of Mullerian inhibiting substance in boys from birth to 18 years, as determined by enzyme immunoassay
11. Serum levels of mullerian inhibiting substance in preterm and term male neonates
12. Anti-Mullerian hormone and testosterone serum levels are inversely related during normal and precocious pubertal development
13. Mullerian inhibiting substance type II receptor expression and function in purified rat Leydig cells
14. Receptors for anti-Mullerian hormone on Leydig cells are responsible for its effects on steroidogenesis and cell differentiation
15. Mullerian inhibiting substance inhibits testosterone synthesis in adult rats
16. Mullerian inhibiting substance lowers testosterone in luteinizing hormone-stimulated rodents
17. Mullerian-inhibiting substance regulates androgen synthesis at the transcriptional level
18. The hormonal response to hCG stimulation in male children and adolescents
19. Pattern of the response of testosterone and its precursors to human chorionic gonadotropin stimulation in relation to age in infants and children
20. Kinetics of the HCG-induced steroidogenic response of the human testes. III. Studies in children of the plasma levels of testosterone and HCG: Rationale for testicular stimulation test
21. How should we perform the human chorionic gonadotropin (hCG) stimulation test?
22. Ontogeny of gonadotropin secretion in congenital anorchism: Sexual dimorphism vs. syndrome of gonadal dysgenesis and diagnostic considerations
23. Elevation of serum gonadotropins establishes the diagnosis of anorchism in prepubertal boys with bilateral cryptorchidism
24. Basal inhibin B and the testosterone response to human chorionic gonadotropin correlate in prepubertal boys
25. Clinical applications of Mullerian inhibiting substance in patients with gonadal disorders
26. Evaluation of gonadal function in 107 intersex patients by means of serum anti-Mullerian hormone measurement
27. Assessment of seminiferous tubule function (anti-Mullerian hormone)
28. Measurement of serum Mullerian inhibiting substance in the evaluation of children with nonpalpable gonads
29. Mullerian inhibiting substance in the diagnosis and management of intersex and gonadal abnormalities
30. Testicular dysgenesis does not affect expression of anti-Mullerian hormone by Sertoli cells in premeiotic seminiferous tubules
31. Paediatric applications of anti-Mullerian hormone research
32. The role of imaging in the management of the impalpable undescended testes
33. The limited role of imaging techniques in managing children with undescended testes
34. The persistent Mullerian duct syndrome: A molecular approach
35. Molecular genetics of the persistent mullerian duct syndrome: A study of 19 families
36. Persistence of Mullerian derivatives in males
37. Evidence from Sertoli cell-depleted rats indicates that spermatid number in adults depends on numbers of Sertoli cell produced during perinatal development
38. Appropriate use and interpretation of human chorionic gonadotropin stimulation in prepubertal male patients